News
Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available for prevention of severe RSV-associated disease in 2023. While clinical trials ...
The study investigated how the Board Independence affects the educational performance of Catholic-founded Grant-Aided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback